| scholarly article | Q13442814 |
| P50 | author | Abdolreza Medghalchi | Q55111993 |
| P2093 | author name string | Yousef Alizadeh | |
| Reza Soltani Moghadam | |||
| Mitra Akbari | |||
| P2860 | cites work | Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management | Q26782424 |
| The evaluation and treatment of graves ophthalmopathy | Q26862144 | ||
| Graves' ophthalmopathy | Q28274196 | ||
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. | Q34010116 | ||
| Thyroid-associated eye disease | Q34027109 | ||
| Epidemiology and prevention of Graves' ophthalmopathy | Q34165523 | ||
| Thyroid associated ophthalmopathy - a review | Q34220709 | ||
| Hyperthyroid vs hypothyroid eye disease: the same severity and activity | Q35542692 | ||
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy | Q35591093 | ||
| Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. | Q35606170 | ||
| Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt | Q36069781 | ||
| An overview of thyroid eye disease | Q36305798 | ||
| VISA Classification for Graves orbitopathy | Q36598248 | ||
| Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India | Q37715255 | ||
| Prevalence and natural history of Graves' orbitopathy in the XXI century | Q38099144 | ||
| Extrathyroidal manifestations of Graves' disease: a 2014 update | Q38218911 | ||
| The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey | Q43579038 | ||
| Classification of the eye changes of Graves' disease. | Q43650306 | ||
| Lower lid retraction in thyroid orbitopathy: lamellar shortening or proptosis? | Q44688138 | ||
| Incidence of hyperthyroidism in Sweden | Q46963719 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Thyroid-associated ophthalmopathy in Iranian patients. | Q50995947 | ||
| Ocular movement disorders and extraocular muscle involvement in Iranian Graves' ophthalmopathy patients. | Q51529629 | ||
| Clinical evaluation of Graves ophthalmopathy in north-east Islamic Republic of Iran. | Q53372481 | ||
| Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy | Q58109526 | ||
| Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease | Q73027928 | ||
| Management of exophthalmos and related ocular changes in Graves' disease | Q74338185 | ||
| P433 | issue | 4 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 353-358 | |
| P577 | publication date | 2018-07-19 | |
| P1433 | published in | Journal of current ophthalmology | Q27727445 |
| P1476 | title | The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran | |
| P478 | volume | 30 |
Search more.